Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
- PMID: 21941004
- PMCID: PMC3825099
- DOI: 10.1136/jmedgenet-2011-100156
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
Abstract
Objective: To investigate the potential contribution of germline sequence alterations in the BAP1 gene in uveal melanoma (UM) patients with possible predisposition to hereditary cancer.
Design: A total of 53 unrelated UM patients with high risk for hereditary cancer and five additional family members of one proband were studied. Mutational screening was carried out by direct sequencing.
Results: Of the 53 UM patients studied, a single patient was identified with a germline BAP1 truncating mutation, c. 799 C→T (p.Q267X), which segregated in several family members and was associated with UM and other cancers. Biallelic inactivation of BAP1 and decreased BAP1 expression were identified in the UM, lung adenocarcinoma and meningioma tumours from three family members with this germline BAP1 mutation. Germline BAP1 variants of uncertain significance, likely non-pathogenic, were also identified in two additional UM patients.
Conclusion: This study reports a novel hereditary cancer syndrome caused by a germline BAP1 mutation that predisposes patients to UM, lung carcinoma, meningioma, and possibly other cancers. The results indicate that BAP1 is the candidate gene in only a small subset of hereditary UM, suggesting the contribution of other candidate genes.
Figures


Similar articles
-
BAP1 germline mutation in two first grade family members with uveal melanoma.Br J Ophthalmol. 2014 Feb;98(2):224-7. doi: 10.1136/bjophthalmol-2013-303814. Epub 2013 Nov 1. Br J Ophthalmol. 2014. PMID: 24187051
-
Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.BMC Cancer. 2018 Nov 26;18(1):1172. doi: 10.1186/s12885-018-5079-x. BMC Cancer. 2018. PMID: 30477459 Free PMC article.
-
Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.Ophthalmic Genet. 2015 Jun;36(2):126-31. doi: 10.3109/13816810.2015.1010734. Epub 2015 Feb 17. Ophthalmic Genet. 2015. PMID: 25687217 Free PMC article.
-
Tumours associated with BAP1 mutations.Pathology. 2013 Feb;45(2):116-26. doi: 10.1097/PAT.0b013e32835d0efb. Pathology. 2013. PMID: 23277170 Review.
-
Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.Cancer Genet. 2013 May;206(5):206-10. doi: 10.1016/j.cancergen.2013.05.018. Cancer Genet. 2013. PMID: 23849051 Review.
Cited by
-
PBRM1 and BAP1 as novel targets for renal cell carcinoma.Cancer J. 2013 Jul-Aug;19(4):324-32. doi: 10.1097/PPO.0b013e3182a102d1. Cancer J. 2013. PMID: 23867514 Free PMC article.
-
Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.Mod Pathol. 2015 Oct;28(10):1360-8. doi: 10.1038/modpathol.2015.87. Epub 2015 Jul 31. Mod Pathol. 2015. PMID: 26226841 Free PMC article.
-
Drosophila as a Potential Model for Ocular Tumors.Ocul Oncol Pathol. 2015 Apr;1(3):190-9. doi: 10.1159/000370155. Epub 2015 Apr 9. Ocul Oncol Pathol. 2015. PMID: 27172095 Free PMC article. Review.
-
Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma.Cancer Sci. 2012 May;103(5):868-74. doi: 10.1111/j.1349-7006.2012.02223.x. Epub 2012 Feb 21. Cancer Sci. 2012. PMID: 22321046 Free PMC article.
-
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.Clin Cancer Res. 2012 Sep 1;18(17):4485-90. doi: 10.1158/1078-0432.CCR-11-2375. Epub 2012 Jul 23. Clin Cancer Res. 2012. PMID: 22825583 Free PMC article.
References
-
- Abdel-Rahman MH, Pilarski R, Ezzat S, Sexton J, Davidorf FH. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Fam Cancer. 2010;9:431–438. - PubMed
-
- Bergman L, Nilsson B, Ragnarsson-Olding B, Seregard S. Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci. 2006;47:72–77. - PubMed
-
- Buecher B, Gauthier-Villars M, Desjardins L, Lumbroso-Le Rouic L, Levy C, De Pauw A, Bombled J, Tirapo C, Houdayer C, Bressac-de Paillerets B, Stoppa-Lyonnet D. Contribution of CDKN2A/P16 (INK4A), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma. Fam Cancer. 2010;9:663–667. - PubMed
-
- Kannengiesser C, Avril MF, Spatz A, Laud K, Lenoir GM, Bressac-de-Paillerets B. CDKN2A as a uveal and cutaneous melanoma susceptibility gene. Genes Chromosomes Cancer. 2003;38:265–268. - PubMed
-
- Abdel-Rahman MH, Pilarski R, Massengill JB, Christopher BN, Noss R, Davidorf FH. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition. Melanoma Res. 2011;21:175–179. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases